Contralateral prophylactic mastectomy: Caveat emptor

Journal of Clinical Oncology

Volumn 27, Issue 9, 2009, Pages 1347-1349

  Recht, Abram ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BRCA2 ONCOGENE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DISTRESS SYNDROME; EDITORIAL; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; ONCOGENE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CONCEPT; SEXUALITY; BREAST TUMOR; CARCINOMA IN SITU; FEMALE; NOTE; PAGET NIPPLE DISEASE; SURVIVAL RATE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASTECTOMY; SURVIVAL RATE;

EID: 63049115508     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.0518     Document Type: Editorial

References (44)

1. Tuttle TM, Jarosek S, Haberman EB, et al: Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362-1367, 2009
2. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007
3. Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84, 1999
4. Eisen A, Rebbeck TR, Wood WC, et al: Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18:1980-1995, 2000
5. Meijers-Heijboer H, van Geel B, van Putten WL, et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159-164, 2001
6. Rebbeck TR, Friebel T, Lynch HT, et al: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22:1055-1062, 2004
7. Lostumo L, Carbine NE, Wallace J, et al: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev issue 9, 2009, doi: 10.1002/14651858.CD002748.pub2
8. Metcalfe K, Lynch HT, Ghadirian P, et al: Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22:2328-2335, 2004
9. Pierce LJ, Levin AM, Rebbeck TR, et al: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 24:2437-2443, 2006
10. Brekelmans CT, Seynaeve C, Menke-Pluymers M, et al: Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17:391-400, 2006
11. Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, et al: Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 43:867-876, 2007
12. Peralta EA, Ellenhorn JDI, Wagman LD, et al: Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180:439-445, 2000
13. Herrinton LJ, Barlow WE, Yu O, et al: Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A Cancer Research Network project. J Clin Oncol 23:4275-4286, 2005
14. Helzlsouer KJ: Contralateral prophylactic mastectomy: Quantifying benefits and weighing the harms. J Clin Oncol 23:4251-4253, 2005
15. Cross CK, Harris J, Recht A: Race, socioeconomic status, and breast carcinoma in the U.S: What have we learned from clinical studies. Cancer 95:1988-1999, 2002
16. Eaker S, Halmin M, Bellocco R, et al: Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden). Int J Cancer 124:180-187, 2009
17. Dalton SO, Schuz J, Engholm G, et al: Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Summary of findings. Eur J Cancer 44:2074-2085, 2008
18. Von Wachenfeldt A, Brandberg Y, Johansson H, et al: Socioeconomic status and quality of life of women with family history of breast cancer attending an oncogenetic counseling clinic: A comparison with general population. Acta Oncol 48:86-92, 2009
19. van Dijk S, van Roosmalen MS, Otten W, et al: Decision making regarding prophylactic mastectomy: Stability of preferences and the impact of anticipated feelings of regret. J Clin Oncol 26:2358-2363, 2008
20. Rosson GD, Singh NK, Ahuja N, et al: Multilevel analysis of the impact of community vs patient factors on access to immediate breast reconstruction following mastectomy in Maryland. Arch Surg 143:1076-1081; discussion 1081, 2008
21. Chen JY, Malin J, Ganz PA, et al: Variation in physician-patient discussion of breast reconstruction. J Gen Intern Med 24:99-104, 2009
22. Hatcher MB, Fallowfield L, A'Hern R: The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. BMJ 322:76, 2001
23. Bresser PJ, Seynaeve C, Van Gool AR, et al: The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingooophorectomy. Eur J Cancer 43:95-103, 2007
24. Brandberg Y, Sandelin K, Erikson S, et al: Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year follow-up study. J Clin Oncol 26:3943-3949, 2008
25. Tercyak KP, Peshkin BN, Brogan BM, et al: Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 25:285-291, 2007
26. Graves KD, Peshkin BN, Halbert CH, et al: Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 104:321-329, 2007
27. van Oostrom I, Meijers-Heijboer H, Lodder LN, et al: Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 21:3867-3874, 2003
28. Geiger AM, Nekhlyudov L, Herrinton LJ, et al: Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14:686-694, 2007
29. Schover LR: A lesser evil: Prophylactic mastectomy for women at high risk for breast cancer. J Clin Oncol 26:3918-3919, 2008
30. Altschuler A, Nekhlyudov L, Rolnick SJ, et al: Positive, negative, and disparate: Women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14:25-32, 2008
31. Molenaar S, Oort F, Sprangers M, et al: Predictors of patients' choices for breast-conserving therapy or mastectomy: A prospective study. Br J Cancer 90:2123-2130, 2004
32. Temple WJ, Russell ML, Parsons LL, et al: Conservation surgery for breast cancer as the preferred choice: A prospective analysis. J Clin Oncol 24:3367-3373, 2006
33. Palda VA, Llewellyn-Thomas HA, Mackenzie RG, et al: Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: Applicability of trade-off methods to policy-making. J Clin Oncol 15:3192-3200, 1997
34. Agrawal M, Emanuel EJ: Ethics of phase 1 oncology studies: Reexamining the arguments and data. JAMA 290:1075-1082, 2003
35. Kirova YM, Stoppa-Lyonnet D, Savignoni A, et al: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 41:2304-2311, 2005
36. Haffty BG, Harrold E, Khan AJ, et al: Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359:1471-1477, 2002
37. Seynaeve C, Verhoog LC, van de Bosch LM, et al: Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 40:1150-1158, 2004
38. Pierce LJ, Griffith KA, Busys S, et al: Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer. J Clin Oncol 26:15s, 2008 (suppl; abstr 536)
39. Eisen A, Lubinski J, Klijn J, et al: Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: An international casecontrol study. J Clin Oncol 23:7491-7496, 2005
40. Kauff ND, Domchek SM, Friebel TM, et al: Risk-reducing salpingooophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. J Clin Oncol 26:1331-1337, 2008
41. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
42. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004
43. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
44. Partridge A, Adloff K, Blood E, et al: Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: Longitudinal results from a cohort study. J Natl Cancer Inst 100:243-251, 2008